z-logo
open-access-imgOpen Access
Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells
Author(s) -
Agarwal Sadhana,
Holton Katherine L.,
Lanza Robert
Publication year - 2008
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1634/stemcells.2007-1102
Subject(s) - biology , endoderm , embryonic stem cell , microbiology and biotechnology , stem cell , cellular differentiation , hepatocyte , directed differentiation , embryoid body , induced pluripotent stem cell , biochemistry , in vitro , gene
Differentiation of human embryonic stem cells (hESCs) to specific functional cell types can be achieved using methods that mimic in vivo embryonic developmental programs. Current protocols for generating hepatocytes from hESCs are hampered by inefficient differentiation procedures that lead to low yields and large cellular heterogeneity. We report here a robust and highly efficient process for the generation of high‐purity (70%) hepatocyte cultures from hESCs that parallels sequential hepatic development in vivo. Highly enriched populations of definitive endoderm were generated from hESCs and then induced to differentiate along the hepatic lineage by the sequential addition of inducing factors implicated in physiological hepatogenesis. The differentiation process was largely uniform, with cell cultures progressively expressing increasing numbers of hepatic lineage markers, including GATA4, HNF4α, α‐fetoprotein, CD26, albumin, α‐1‐antitrypsin, Cyp7A1, and Cyp3A4. The hepatocytes exhibited functional hepatic characteristics, such as glycogen storage, indocyanine green uptake and release, and albumin secretion. In a mouse model of acute liver injury, the hESC‐derived definitive endoderm differentiated into hepatocytes and repopulated the damaged liver. The methodology described here represents a significant step toward the efficient generation of hepatocytes for use in regenerative medicine and drug discovery. Disclosure of potential conflicts of interest is found at the end of this article.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here